Emodin modulates gut microbial community and triggers intestinal immunity
- PMID: 36088620
- PMCID: PMC10087506
- DOI: 10.1002/jsfa.12221
Emodin modulates gut microbial community and triggers intestinal immunity
Abstract
Background: The gut microbiota (GM) plays an important role in human health and is being investigated as a possible target for new therapies. Although there are many studies showing that emodin can improve host health, emodin-GM studies are scarce. Here, the effects of emodin on the GM were investigated in vitro and in vivo.
Results: In vitro single bacteria cultivation showed that emodin stimulated the growth of beneficial bacteria Akkermansia, Clostridium, Roseburia, and Ruminococcus but inhibited major gut enterotypes (Bacteroides and Prevotella). Microbial community analysis from a synthetic gut microbiome model through co-culture indicated the consistent GM change by emodin. Interestingly, emodin stimulated Clostridium and Ruminococcus (which are related to Roseburia and Faecalibacterium) in a mice experiment and induced anti-inflammatory immune cells, which may correlate with its impact on specific gut bacteria.
Conclusion: Emodin (i) showed similar GM changes in monoculture, co-culture, and in an in vivo mice experiment and (ii) simulated regulatory T-cell immune responses in vivo. This suggest that emodin may be used to modulate the GM and improve health. © 2022 The Authors. Journal of The Science of Food and Agriculture published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
Keywords: MiSeq; T regulatory cell; emodin; gut microbiome.
© 2022 The Authors. Journal of The Science of Food and Agriculture published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
Conflict of interest statement
The authors declare no competing financial interest.
Figures





Similar articles
-
Gut dysbiosis, inflammation and type 2 diabetes in mice using synthetic gut microbiota from diabetic humans.Braz J Biol. 2021 Aug 6;83:e242818. doi: 10.1590/1519-6984.242818. eCollection 2021. Braz J Biol. 2021. PMID: 34378656
-
The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection.Front Cell Infect Microbiol. 2022 Jul 8;12:908492. doi: 10.3389/fcimb.2022.908492. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35873161 Free PMC article.
-
Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.Oncotarget. 2016 Apr 5;7(14):17468-78. doi: 10.18632/oncotarget.8160. Oncotarget. 2016. PMID: 27003359 Free PMC article.
-
Gut Microbiota Dysbiosis in Human Obesity: Impact of Bariatric Surgery.Curr Obes Rep. 2019 Sep;8(3):229-242. doi: 10.1007/s13679-019-00351-3. Curr Obes Rep. 2019. PMID: 31197613 Review.
-
The effects of inulin on gut microbial composition: a systematic review of evidence from human studies.Eur J Clin Microbiol Infect Dis. 2020 Mar;39(3):403-413. doi: 10.1007/s10096-019-03721-w. Epub 2019 Nov 9. Eur J Clin Microbiol Infect Dis. 2020. PMID: 31707507
Cited by
-
DL-Methionyl-DL-Methionine/DL-Methionine Supplementation Alleviated the Adverse Effects of Dietary Low Fishmeal Levels on Growth and Intestinal Health of Micropterus salmoides.Antioxidants (Basel). 2024 Mar 18;13(3):359. doi: 10.3390/antiox13030359. Antioxidants (Basel). 2024. PMID: 38539892 Free PMC article.
-
Emodin, a Natural Anthraquinone, Increases Uric Acid Excretion in Rats with Potassium Oxonate-Induced Hyperuricemia.Pharmaceuticals (Basel). 2023 May 25;16(6):789. doi: 10.3390/ph16060789. Pharmaceuticals (Basel). 2023. PMID: 37375737 Free PMC article.
-
Targeted remodeling of the human gut microbiome using Juemingzi (Senna seed extracts).Front Cell Infect Microbiol. 2024 Apr 4;14:1296619. doi: 10.3389/fcimb.2024.1296619. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38638830 Free PMC article.
-
Advances in the pharmacological effects and molecular mechanisms of emodin in the treatment of metabolic diseases.Front Pharmacol. 2023 Oct 31;14:1240820. doi: 10.3389/fphar.2023.1240820. eCollection 2023. Front Pharmacol. 2023. PMID: 38027005 Free PMC article. Review.
References
-
- Monks TJ, Hanzlik RP, Cohen GM, Ross D and Graham DG, Quinone chemistry and toxicity. Toxicol Appl Pharmacol 112:2–16 (1992). - PubMed
-
- Shia CS, Hou YC, Tsai SY, Huieh PH, Leu YL and Chao PD, Differences in pharmacokinetics and ex vivo antioxidant activity following intravenous and oral administrations of emodin to rats. J Pharm Sci 99:2185–2195 (2010). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources